Antibacterial Efficacy of R-Type Pyocins towards Pseudomonas aeruginosa in a Murine Peritonitis Model

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2008-03-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.01479-07PMID 18332164PMCID PMC2346647
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of Bacteriophage Therapy against Gut-Derived Sepsis Caused by Pseudomonas aeruginosa in Mice

  2006influential reference
• Erratum: Bad bugs need drugs: An update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America (Clinical Infectious Diseases (March 1, 2006) 42 (657-668))

  2006cited by this paper
• Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.

  2006cited by this paper
• Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.

  2006cited by this paper
• Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.

  2005cited by this paper
• Bacteriophage penetration in vertebrates

  2005cited by this paper
• Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage

  2004cited by this paper
• An in vitro human cell-based assay to rank the relative immunogenicity of proteins.

  2004cited by this paper
• Genetic determinant of pyocin R2 in Pseudomonas aeruginosa PAO

  2004cited by this paper
• Characterization of Enterocoliticin, a Phage Tail-Like Bacteriocin, and Its Effect on Pathogenic Yersinia enterocolitica Strains

  2001cited by this paper
• The R‐type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F‐type is related to lambda phage

  2000cited by this paper
• Efficacy of Locally Delivered Polyclonal Immunoglobulin against Pseudomonas aeruginosa Peritonitis in a Murine Model

  1999cited by this paper
• Peritonitis: update on pathophysiology, clinical manifestations, and management.

  1997cited by this paper
• Long-circulating bacteriophage as antibacterial agents.

  1996cited by this paper
• Characterization of cryptic prophages (monocins) in Listeria and sequence analysis of a holin/endolysin gene.

  1995cited by this paper
• Pseudomonas peritonitis associated with continuous ambulatory peritoneal dialysis: a six-year study.

  1988cited by this paper
• Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis

  1987cited by this paper
• Pseudomonas aeruginosa as a primary pathogen in children with bacterial peritonitis.

  1987cited by this paper
• The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis.

  1985cited by this paper
• Pyocin R1 inhibits active transport in Pseudomonas aeruginosa and depolarizes membrane potential

  1984cited by this paper
• Genetic determinant of pyocin R2 in Pseudomonas aeruginosa PAO

  1983cited by this paper
• Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis.

  1982cited by this paper
• Specific Cleavage at Fibers of a Bacteriophage-Tail-Like Bacteriocin, Pyocin R1, by Successive Treatment with Organomercurial Compounds and Trypsin

  1982cited by this paper
• 1 – Physical and Chemical Properties

  1981cited by this paper
• Genetic transformation in Staphylococcus aureus: demonstration of a competence-conferring factor of bacteriophage origin in bacteriophage 80 alpha lysates

  1981cited by this paper
• Mode of action of pyocin R1.

  1978cited by this paper
• Protective effect of pyocin against lethal Pseudomonas aeruginosa infections in mice.

  1974cited by this paper
• Experimental Intra-Abdominal Abscesses in Rats: Development of an Experimental Model

  1974cited by this paper
• Use of pyocin 78-C2 in the treatment of Pseudomonas aeruginosa infection in mice.

  1972cited by this paper
• ISOLATION AND CHARACTERIZATION OF PYOCINS FROM SEVERAL STRAINS OF PSEUDOMONAS AERUGINOSA

  1970cited by this paper
• Rod-shaped pyocin 28.

  1969cited by this paper
• Bacteriophage-tail-like particles associated with intra-species killing of Proteus vulgaris.

  1968cited by this paper
• The fine structure of a pyocin.

  1965cited by this paper
• STUDIES OF A PYOCIN. I. PHYSICAL AND CHEMICAL PROPERTIES.

  1964cited by this paper
• STUDIES OF A PYOCIN. III. BIOLOGICAL PROPERTIES OF THE PYOCIN.

  1964cited by this paper
• On the purification and some properties of a pyocin, a bacteriocin produced by Pseudomonas aeruginosa.

  1962cited by this paper
• STUDIES ON PYOCIN

  1962cited by this paper
• [Induced biosynthesis and mode of action of a pyocine, antibiotic produced by Pseudomonas aeruginosa].

  1954cited by this paper

• Role of R5 pyocin in the predominance of high-risk Pseudomonas aeruginosa isolates

  2025cites this paper
• The world of phage tail-like bacteriocins: State of the art and biotechnological perspectives.

  2025cites this paper
• R-pyocins as targeted antimicrobials against Pseudomonas aeruginosa

  2025influential citation
• Identification and Functional Insights into New Phage Tail-Like Bacteriocins (PTLBs) Targeting Pseudomonas aeruginosa as new antimicrobials

  2025cites this paper
• A VersaTile Approach to Reprogram the Specificity of the R2-Type Tailocin Towards Different Serotypes of Escherichia coli and Klebsiella pneumoniae

  2024cites this paper
• Role of R5 Pyocin in the Predominance of High-Risk Pseudomonas aeruginosa Isolates

  2024cites this paper
• Pyocins and Beyond: Exploring the World of Bacteriocins in Pseudomonas aeruginosa

  2024cites this paper
• Bacteriocins: potentials and prospects in health and agrifood systems

  2024cites this paper
• Strategies for developing phages into novel antimicrobial tailocins.

  2024cites this paper
• Genomic correlates of tailocin sensitivity in Pseudomonas syringae

  2024cites this paper
• EF-hand calcium sensor, EfhP, controls transcriptional regulation of iron uptake by calcium in Pseudomonas aeruginosa

  2024cites this paper
• Evolutionary and ecological role of extracellular contractile injection systems: from threat to weapon

  2023cites this paper
• Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents

  2023cites this paper
• Engineering of Salmonella Phages into Novel Antimicrobial Tailocins

  2023cites this paper
• Soft rot pathogen Dickeya dadantii 3937 produces tailocins resembling the tails of Peduovirus P2

  2023cites this paper
• Soft rot pathogen Dickeya dadantii 3937 produces tailocins resembling the tails of Enterobacteria bacteriophage P2

  2023cites this paper
• Comprehensive Approaches for the Search and Characterization of Staphylococcins

  2023cites this paper
• F-Type Pyocins Are Diverse Noncontractile Phage Tail-Like Weapons for Killing Pseudomonas aeruginosa

  2023cites this paper
• The In Vivo and In Vitro Assessment of Pyocins in Treating Pseudomonas aeruginosa Infections

  2022cites this paper
• Chimeric bacteriocin S5-PmnH engineered by domain swapping efficiently controls Pseudomonas aeruginosa infection in murine keratitis and lung models

  2022cites this paper
• Antimicrobial Weapons of Pseudomonas aeruginosa.

  2022cites this paper
• Use of Bacteriocins and Bacteriocinogenic Beneficial Organisms in Food Products: Benefits, Challenges, Concerns

  2022cites this paper
• Pseudomonas aeruginosa and Its Pathogenicity

  2022cites this paper
• Quantitative description of a contractile macromolecular machine

  2021cites this paper
• F-type Pyocins are Diverse Non-Contractile Phage Tail-Like Weapons for Killing Pseudomonas aeruginosa

  2021cites this paper
• Enzybiotics: Endolysins and Bacteriocins

  2021cites this paper
• SOS-Independent Pyocin Production in P. aeruginosa Is Induced by XerC Recombinase Deficiency

  2021cites this paper
• Recombinant R2-pyocin cream is effective in treating Pseudomonas aeruginosa-infected wounds.

  2021cites this paper
• Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs

  2021cites this paper
• Structural design principles for specific ultra-high affinity interactions between colicins/pyocins and immunity proteins

  2021cites this paper
• Heterogenous Susceptibility to R-Pyocins in Populations of <named-content content-type='genus-species'>Pseudomonas aeruginosa</named-content> Sourced from Cystic Fibrosis Lungs

  2021cites this paper
• Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields

  2021cites this paper
• Bacteriocins in the Era of Antibiotic Resistance: Rising to the Challenge

  2021cites this paper
• Harnessing bacterial interactions to manage infections: a review on the opportunistic pathogen Pseudomonas aeruginosa as a case example.

  2020cites this paper
• Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations

  2020cites this paper
• Heterogenous response to R-pyocin killing in populations of Pseudomonas aeruginosa sourced from cystic fibrosis lungs

  2020cites this paper
• Antibacterial efficacy of R-type pyocins against Pseudomonas aeruginosa on biofilms and in a murine model of acute lung infection.

  2020cites this paper
• Murine Models for Development of Anti-Infective Therapeutics

  2020cites this paper
• Action of a minimal contractile bactericidal nanomachine

  2020cites this paper
• Full Transcriptomic Response of Pseudomonas aeruginosa to an Inulin-Derived Fructooligosaccharide

  2020cites this paper
• Bioactivity and genome guided isolation of a novel antimicrobial protein from Thalassomonas viridans

  2019cites this paper
• Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages

  2019cites this paper
• Characterization of maltocin S16, a phage tail‐like bacteriocin with antibacterial activity against Stenotrophomonas maltophilia and Escherichia coli

  2019cites this paper
• Bacterial Proteinaceous Compounds With Multiple Activities Toward Cancers and Microbial Infection

  2019cites this paper
• Characterization of the bacteriocins and the PrtR regulator in a plant-associated Pseudomonas strain.

  2019influential citation
• Co-existence of Citrobacter freundii exacerbated Pseudomonas aeruginosa infection in vivo.

  2019cites this paper
• The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology

  2019cites this paper
• Competition in Biofilms between Cystic Fibrosis Isolates of Pseudomonas aeruginosa Is Shaped by R-Pyocins

  2019cites this paper
• Competition in biofilms between cystic fibrosis isolates of Pseudomonas aeruginosa is shaped by R-pyocins

  2018cites this paper
• Antibacterial Weapons: Targeted Destruction in the Microbiota.

  2018cites this paper
• Effectiveness of tailocins produced by Pseudomonas fluorescens SF4c in controlling the bacterial-spot disease in tomatoes caused by Xanthomonas vesicatoria.

  2018cites this paper
• Pseudomonas chlororaphis Produces Multiple R-Tailocin Particles That Broaden the Killing Spectrum and Contribute to Persistence in Rhizosphere Communities

  2018cites this paper
• Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients

  2018cites this paper
• Crystal Structures of R-Type Bacteriocin Sheath and Tube Proteins CD1363 and CD1364 From Clostridium difficile in the Pre-assembled State

  2018cites this paper
• Structure and Analysis of R1 and R2 Pyocin Receptor-Binding Fibers

  2018cites this paper
• Crystal structure of the R-type bacteriocin tube protein CD1364 from Clostridium difficile in the pre-assembled state

  2018cites this paper
• Discovery and Characterization of an Antimicrobial Toxin of the Gut Symbiont Bacteroides fragilis

  2018cites this paper
• A Broad-Host-Range Tailocin from Burkholderia cenocepacia

  2017cites this paper
• Tn6350, a Novel Transposon Carrying Pyocin S8 Genes Encoding a Bacteriocin with Activity against Carbapenemase-Producing Pseudomonas aeruginosa

  2017cites this paper
• PHAGE THERAPY AGAINST PSEUDOMONAS AERUGINOSA CROSS-REFERENCE TO RELATED APPLICATIONS

  2017cites this paper
• Infection therapy: the problem of drug resistance – and possible solutions

  2017cites this paper
• Phage Tail-Like Bacteriocins.

  2017cites this paper
• Plant-expressed pyocins for control of Pseudomonas aeruginosa

  2017cites this paper
• Genomic approaches to characterizing and reducing antimicrobial resistance in beef cattle production systems

  2017cites this paper
• Avaliação da atividade bactericida da piocina S8 contra cepas de Pseudomonas aeruginosa multirresistentes.

  2017cites this paper
• Effect of a Pseudomonas fluorescens tailocin against phytopathogenic Xanthomonas observed by atomic force microscopy.

  2017cites this paper
• The therapeutic potential of bacteriocins as protein antibiotics

  2017cites this paper
• Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studies.

  2016cites this paper
• Aislamiento, caracterización y estudios de actividad de bacteriófagos líticos sobre Enterococcus spp. en modelos in vivo e in vitro

  2016cites this paper
• Phage tail-like particles kill Clostridium difficile and represent an alternative to conventional antibiotics.

  2015cites this paper
• The effect of antibiotics on Pseudomonas aeruginosa biofilm production

  2015cites this paper
• Controlling Pseudomonas aeruginosa Persister Cells by Human Granulocyte Macrophage Colony-Stimulating Factor

  2015cites this paper
• Biophysicochemical characterization of Pyocin SA189 produced by Pseudomonas aeruginosa SA189

  2015cites this paper
• Within-host competitive interactions as a mechanism for the maintenance of parasite diversity

  2015cites this paper
• Human Granulocyte Macrophage Colony-Stimulating Factor Enhances Antibiotic Susceptibility of Pseudomonas aeruginosa Persister Cells

  2015cites this paper
• Ribosomally encoded antibacterial proteins and peptides from Pseudomonas.

  2014cites this paper
• Structure and Function of Essential Components of Contractile Injection Systems

  2014cites this paper
• Molecular characterization of a novel pyocin and its immunity protein in pseudomonas aeruginosa

  2014cites this paper
• USING e-ANNOTATION TOOLS FOR ELECTRONIC PROOF CORRECTION

  2014cites this paper
• Phage Therapy: Eco-Physiological Pharmacology

  2014cites this paper
• Antimicrobial protein produced by pseudomonas aeruginosa JU-Ch 1, with a broad spectrum of antimicrobial activity

  2014cites this paper
• Peptides as the next generation of anti-infectives.

  2013cites this paper
• Engineering microbes to sense and eradicate a human pathogen

  2013cites this paper
• Listeria phages

  2013cites this paper
• Staphylococcus bacteriophage tails with bactericidal properties: New findings

  2012cites this paper
• Genome Sequence of E. coli O104:H4 Leads to Rapid Development of a Targeted Antimicrobial Agent against This Emerging Pathogen

  2012cites this paper
• Characterization of a broad host range tailocin from Burkholderia

  2012influential citation
• Characterization of a phage-like pyocin from the plant growth-promoting rhizobacterium Pseudomonas fluorescens SF4c.

  2012cites this paper
• Bacterial signaling systems as platforms for rational design of new generations of biosensors.

  2012cites this paper
• Novel High-Molecular-Weight, R-Type Bacteriocins of Clostridium difficile

  2012influential citation
• Novel therapeutic strategies to counter Pseudomonas aeruginosa infections

  2012cites this paper
• Therapeutic Potential of Anti-Microbial Peptides from Insects

  2011cites this paper
• Antimicrobial Peptides: Diversity and Perspectives for Their Biomedical Application

  2011cites this paper
• An Escherichia coli O157-Specific Engineered Pyocin Prevents and Ameliorates Infection by E. coli O157:H7 in an Animal Model of Diarrheal Disease

  2011cites this paper
• Characterizing the Pyocin Activity of Diverse Pseudomonas aeruginosa Isolates

  2011cites this paper
• Mycoviruses: future therapeutic agents of invasive fungal infections in humans?

  2010cites this paper
• Phage therapy pharmacology.

  2010cites this paper
• The Post-Antibiotic Era: Promising Developments in the Therapy of Infectious Diseases

  2010cites this paper
• Lipopolysaccharide as Shield and Receptor for R-Pyocin-Mediated Killing in Pseudomonas aeruginosa

  2010cites this paper
• A predicted S‐type pyocin shows a bactericidal activity against clinical Pseudomonas aeruginosa isolates through membrane damage

  2010cites this paper